Concepts (195)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cannabinoids | 4 | 2024 | 173 | 2.130 |
Why?
|
Cannabis | 5 | 2024 | 436 | 1.910 |
Why?
|
Neoplasms | 32 | 2024 | 22075 | 1.820 |
Why?
|
Cannabidiol | 2 | 2023 | 117 | 1.480 |
Why?
|
Socialization | 1 | 2019 | 86 | 0.680 |
Why?
|
Hematology | 1 | 2022 | 241 | 0.620 |
Why?
|
Survivors | 4 | 2020 | 2375 | 0.580 |
Why?
|
Medical Oncology | 5 | 2023 | 2313 | 0.500 |
Why?
|
Neurosciences | 1 | 2019 | 353 | 0.490 |
Why?
|
Culture | 1 | 2018 | 622 | 0.460 |
Why?
|
Social Behavior | 1 | 2019 | 1131 | 0.430 |
Why?
|
Amygdala | 1 | 2019 | 1351 | 0.390 |
Why?
|
Behavior, Animal | 1 | 2019 | 1866 | 0.390 |
Why?
|
Physician's Role | 1 | 2018 | 918 | 0.390 |
Why?
|
Anxiety | 5 | 2022 | 4538 | 0.330 |
Why?
|
Psychotropic Drugs | 1 | 2014 | 883 | 0.320 |
Why?
|
Mental Disorders | 4 | 2022 | 6796 | 0.300 |
Why?
|
Interferon-alpha | 1 | 2012 | 919 | 0.300 |
Why?
|
Nausea | 2 | 2021 | 678 | 0.270 |
Why?
|
Fatigue | 3 | 2021 | 1544 | 0.270 |
Why?
|
Transcription, Genetic | 1 | 2019 | 7593 | 0.260 |
Why?
|
Decision Support Systems, Clinical | 3 | 2021 | 1164 | 0.240 |
Why?
|
Health Knowledge, Attitudes, Practice | 2 | 2024 | 3985 | 0.240 |
Why?
|
Personality | 1 | 2008 | 552 | 0.230 |
Why?
|
Fellowships and Scholarships | 2 | 2024 | 1116 | 0.230 |
Why?
|
Humans | 52 | 2024 | 760613 | 0.220 |
Why?
|
Models, Biological | 1 | 2019 | 9468 | 0.220 |
Why?
|
Immunologic Factors | 1 | 2012 | 1588 | 0.210 |
Why?
|
Adult | 26 | 2024 | 220007 | 0.210 |
Why?
|
Attitude of Health Personnel | 4 | 2024 | 3865 | 0.200 |
Why?
|
Self Concept | 1 | 2008 | 1039 | 0.200 |
Why?
|
Substance-Related Disorders | 3 | 2022 | 4371 | 0.170 |
Why?
|
Cognition Disorders | 2 | 2012 | 3976 | 0.170 |
Why?
|
Palliative Care | 6 | 2024 | 3607 | 0.170 |
Why?
|
Mice, Inbred DBA | 1 | 2019 | 622 | 0.160 |
Why?
|
United States | 12 | 2024 | 72448 | 0.150 |
Why?
|
Female | 29 | 2024 | 391246 | 0.150 |
Why?
|
Malignant Carcinoid Syndrome | 1 | 2017 | 30 | 0.140 |
Why?
|
Genital Neoplasms, Female | 1 | 2022 | 533 | 0.140 |
Why?
|
Hallucinogens | 1 | 2020 | 194 | 0.140 |
Why?
|
Analgesics, Opioid | 4 | 2023 | 3763 | 0.140 |
Why?
|
Male | 25 | 2024 | 359718 | 0.130 |
Why?
|
Social Stigma | 1 | 2022 | 734 | 0.130 |
Why?
|
Cardiac Resynchronization Therapy | 1 | 2022 | 553 | 0.130 |
Why?
|
Attitude | 1 | 2021 | 777 | 0.130 |
Why?
|
Peritoneal Neoplasms | 1 | 2022 | 707 | 0.130 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2019 | 626 | 0.120 |
Why?
|
Health Personnel | 3 | 2022 | 3310 | 0.120 |
Why?
|
Program Development | 2 | 2018 | 1297 | 0.120 |
Why?
|
Quality of Life | 7 | 2021 | 13308 | 0.120 |
Why?
|
Depression | 4 | 2021 | 8045 | 0.110 |
Why?
|
Evidence-Based Medicine | 3 | 2018 | 3696 | 0.110 |
Why?
|
Comparative Effectiveness Research | 1 | 2019 | 718 | 0.110 |
Why?
|
Melanoma | 1 | 2012 | 5697 | 0.110 |
Why?
|
Standard of Care | 1 | 2017 | 552 | 0.110 |
Why?
|
Skin Neoplasms | 1 | 2012 | 5799 | 0.100 |
Why?
|
Arthritis, Rheumatoid | 1 | 2008 | 3763 | 0.100 |
Why?
|
Burnout, Professional | 1 | 2021 | 702 | 0.100 |
Why?
|
Adaptation, Psychological | 3 | 2023 | 2628 | 0.100 |
Why?
|
Comorbidity | 2 | 2019 | 10553 | 0.090 |
Why?
|
Middle Aged | 18 | 2021 | 220359 | 0.090 |
Why?
|
Mice, Inbred BALB C | 1 | 2019 | 6216 | 0.090 |
Why?
|
Health Education | 1 | 2017 | 1049 | 0.090 |
Why?
|
Diagnostic Self Evaluation | 1 | 2012 | 225 | 0.090 |
Why?
|
Analgesics | 1 | 2017 | 1065 | 0.090 |
Why?
|
Telemedicine | 2 | 2017 | 3018 | 0.090 |
Why?
|
Education, Medical, Graduate | 1 | 2022 | 2363 | 0.080 |
Why?
|
Program Evaluation | 1 | 2018 | 2493 | 0.080 |
Why?
|
Severity of Illness Index | 4 | 2014 | 15840 | 0.080 |
Why?
|
Caregivers | 2 | 2022 | 2224 | 0.080 |
Why?
|
Drug Prescriptions | 1 | 2018 | 1673 | 0.080 |
Why?
|
Needs Assessment | 1 | 2015 | 1139 | 0.080 |
Why?
|
Opioid-Related Disorders | 1 | 2023 | 2138 | 0.080 |
Why?
|
Interview, Psychological | 1 | 2012 | 810 | 0.080 |
Why?
|
Focus Groups | 3 | 2018 | 1378 | 0.070 |
Why?
|
Counseling | 1 | 2015 | 1548 | 0.070 |
Why?
|
Aged | 11 | 2022 | 169143 | 0.070 |
Why?
|
Epidemiologic Methods | 1 | 2012 | 1343 | 0.070 |
Why?
|
Terminal Care | 1 | 2019 | 1758 | 0.070 |
Why?
|
Decision Making | 1 | 2020 | 3925 | 0.070 |
Why?
|
Health Policy | 1 | 2018 | 2677 | 0.070 |
Why?
|
Algorithms | 2 | 2018 | 13982 | 0.060 |
Why?
|
Internet | 2 | 2015 | 3078 | 0.060 |
Why?
|
Deglutition | 1 | 2007 | 208 | 0.060 |
Why?
|
Sleep | 1 | 2021 | 4750 | 0.060 |
Why?
|
Societies, Medical | 1 | 2017 | 3905 | 0.060 |
Why?
|
Memory Disorders | 1 | 2012 | 1197 | 0.060 |
Why?
|
Logistic Models | 2 | 2021 | 13312 | 0.060 |
Why?
|
Somatosensory Cortex | 1 | 2008 | 511 | 0.060 |
Why?
|
Brain Neoplasms | 2 | 2022 | 8985 | 0.060 |
Why?
|
Lung Neoplasms | 2 | 2021 | 13262 | 0.060 |
Why?
|
Physician-Patient Relations | 1 | 2017 | 3242 | 0.060 |
Why?
|
Attitude to Health | 1 | 2012 | 2029 | 0.050 |
Why?
|
Foreign Bodies | 1 | 2007 | 397 | 0.050 |
Why?
|
Health Surveys | 2 | 2014 | 4063 | 0.050 |
Why?
|
Databases, Factual | 1 | 2018 | 8022 | 0.050 |
Why?
|
Recombinant Proteins | 1 | 2012 | 6538 | 0.050 |
Why?
|
Personality Disorders | 1 | 2007 | 721 | 0.050 |
Why?
|
Proxy | 1 | 2022 | 148 | 0.050 |
Why?
|
Mice, Inbred C57BL | 1 | 2019 | 22020 | 0.050 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2018 | 10343 | 0.050 |
Why?
|
Ambulatory Care | 2 | 2017 | 2782 | 0.050 |
Why?
|
Nurse's Role | 1 | 2022 | 188 | 0.040 |
Why?
|
Disease Models, Animal | 1 | 2019 | 18137 | 0.040 |
Why?
|
Existentialism | 1 | 2020 | 38 | 0.040 |
Why?
|
Case-Control Studies | 2 | 2014 | 22052 | 0.040 |
Why?
|
Cobalt Radioisotopes | 1 | 1999 | 75 | 0.040 |
Why?
|
Computers | 1 | 2022 | 595 | 0.040 |
Why?
|
Apolipoproteins E | 1 | 2005 | 1437 | 0.040 |
Why?
|
Models, Psychological | 1 | 2023 | 827 | 0.040 |
Why?
|
Stress, Psychological | 1 | 2014 | 4446 | 0.040 |
Why?
|
Mass Screening | 1 | 2014 | 5422 | 0.040 |
Why?
|
Antirheumatic Agents | 1 | 2008 | 1374 | 0.040 |
Why?
|
Depressive Disorder | 1 | 2011 | 3726 | 0.040 |
Why?
|
Socioeconomic Factors | 1 | 2012 | 7805 | 0.040 |
Why?
|
Feasibility Studies | 2 | 2022 | 5201 | 0.040 |
Why?
|
Heart Failure | 1 | 2022 | 11848 | 0.040 |
Why?
|
Illinois | 1 | 2017 | 118 | 0.040 |
Why?
|
Hydroxyindoleacetic Acid | 1 | 2017 | 93 | 0.040 |
Why?
|
Washington | 1 | 2017 | 312 | 0.040 |
Why?
|
Flushing | 1 | 2017 | 52 | 0.040 |
Why?
|
Depressive Disorder, Major | 1 | 2014 | 4744 | 0.030 |
Why?
|
Self Efficacy | 1 | 2020 | 630 | 0.030 |
Why?
|
Documentation | 1 | 2022 | 893 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2008 | 10826 | 0.030 |
Why?
|
Movement Disorders | 1 | 1999 | 459 | 0.030 |
Why?
|
Somatoform Disorders | 2 | 2014 | 423 | 0.030 |
Why?
|
Carcinoid Tumor | 1 | 2017 | 228 | 0.030 |
Why?
|
Affect | 1 | 2022 | 1480 | 0.030 |
Why?
|
Young Adult | 5 | 2021 | 58748 | 0.030 |
Why?
|
Cancer Care Facilities | 1 | 2017 | 424 | 0.030 |
Why?
|
Practice Guidelines as Topic | 1 | 2012 | 7475 | 0.030 |
Why?
|
Canada | 1 | 2020 | 2126 | 0.030 |
Why?
|
Multivariate Analysis | 1 | 2008 | 12159 | 0.030 |
Why?
|
Adolescent | 5 | 2021 | 87809 | 0.030 |
Why?
|
Prevalence | 2 | 2021 | 15686 | 0.030 |
Why?
|
Dyspnea | 1 | 2021 | 1353 | 0.030 |
Why?
|
Information Services | 1 | 2015 | 235 | 0.030 |
Why?
|
Natural Language Processing | 1 | 2022 | 1135 | 0.030 |
Why?
|
Mice | 1 | 2019 | 81209 | 0.030 |
Why?
|
Referral and Consultation | 2 | 2015 | 3598 | 0.020 |
Why?
|
Health Behavior | 1 | 2023 | 2622 | 0.020 |
Why?
|
Critical Care | 1 | 2023 | 2699 | 0.020 |
Why?
|
Critical Illness | 1 | 2023 | 2709 | 0.020 |
Why?
|
Guidelines as Topic | 1 | 2017 | 1392 | 0.020 |
Why?
|
Cognition | 1 | 2008 | 6964 | 0.020 |
Why?
|
Population Surveillance | 1 | 2021 | 2608 | 0.020 |
Why?
|
Diarrhea | 1 | 2017 | 1319 | 0.020 |
Why?
|
Radiopharmaceuticals | 1 | 1999 | 2634 | 0.020 |
Why?
|
Qualitative Research | 1 | 2020 | 2963 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2017 | 21029 | 0.020 |
Why?
|
Antineoplastic Agents | 1 | 2012 | 13627 | 0.020 |
Why?
|
Medical Records | 1 | 2014 | 1407 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2021 | 25941 | 0.020 |
Why?
|
Patient Participation | 1 | 2017 | 1439 | 0.020 |
Why?
|
Animals | 1 | 2019 | 167960 | 0.020 |
Why?
|
Pain | 1 | 2021 | 5066 | 0.020 |
Why?
|
Malingering | 1 | 2007 | 75 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2017 | 4902 | 0.020 |
Why?
|
Social Support | 1 | 2015 | 2145 | 0.020 |
Why?
|
Electronic Health Records | 1 | 2022 | 4775 | 0.020 |
Why?
|
Massachusetts | 1 | 2017 | 8803 | 0.010 |
Why?
|
Psychometrics | 1 | 2014 | 3051 | 0.010 |
Why?
|
Glioblastoma | 1 | 1999 | 3482 | 0.010 |
Why?
|
Alzheimer Disease | 1 | 2005 | 8561 | 0.010 |
Why?
|
Communication | 1 | 2017 | 3849 | 0.010 |
Why?
|
Pandemics | 1 | 2023 | 8623 | 0.010 |
Why?
|
Aged, 80 and over | 2 | 2021 | 58980 | 0.010 |
Why?
|
Recurrence | 1 | 2014 | 8483 | 0.010 |
Why?
|
Hospitalization | 1 | 2022 | 10789 | 0.010 |
Why?
|
Diagnosis, Differential | 2 | 2011 | 12968 | 0.010 |
Why?
|
Mental Health | 1 | 2015 | 3213 | 0.010 |
Why?
|
Apolipoprotein E4 | 1 | 2005 | 709 | 0.010 |
Why?
|
Actuarial Analysis | 1 | 1999 | 374 | 0.010 |
Why?
|
Karnofsky Performance Status | 1 | 1999 | 165 | 0.010 |
Why?
|
Supratentorial Neoplasms | 1 | 1999 | 159 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2017 | 64981 | 0.010 |
Why?
|
Necrosis | 1 | 1999 | 1612 | 0.010 |
Why?
|
Prospective Studies | 2 | 2014 | 54306 | 0.010 |
Why?
|
Gadolinium | 1 | 1999 | 959 | 0.010 |
Why?
|
Child | 2 | 2017 | 79799 | 0.010 |
Why?
|
Follow-Up Studies | 2 | 2005 | 39262 | 0.010 |
Why?
|
Genotype | 1 | 2005 | 12957 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2005 | 14494 | 0.000 |
Why?
|
Predictive Value of Tests | 1 | 2005 | 15286 | 0.000 |
Why?
|
Retrospective Studies | 1 | 2017 | 80345 | 0.000 |
Why?
|
Risk Factors | 1 | 2014 | 74333 | 0.000 |
Why?
|
Contrast Media | 1 | 1999 | 5305 | 0.000 |
Why?
|
Antipsychotic Agents | 1 | 1999 | 3061 | 0.000 |
Why?
|
Survival Rate | 1 | 1999 | 12810 | 0.000 |
Why?
|
Neoplasm Recurrence, Local | 1 | 1999 | 9278 | 0.000 |
Why?
|
Prognosis | 1 | 1999 | 29661 | 0.000 |
Why?
|
Genetic Predisposition to Disease | 1 | 1999 | 17790 | 0.000 |
Why?
|
Infant | 1 | 1999 | 36053 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 1 | 1999 | 36286 | 0.000 |
Why?
|
Concepts
(195)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(61)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_